News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard May 20, 2022 StatementGlobal healthCOVID-19 Novavax Files in the European Union for Expanded Conditional Marketing Authorization of COVID-19 Vaccine as a Booster in Individuals Aged 18 and Over Download May 13, 2022 StatementCOVID-19 Novavax Files for Emergency Use Authorization of COVID-19 Vaccine in Taiwan Download May 9, 2022 Press releaseCorporate and finance Novavax Reports First Quarter 2022 Financial Results and Operational Highlights Download May 6, 2022 StatementCOVID-19 Novavax Submits Variations to Expand Australian and New Zealand Provisional Approval of Nuvaxovid™ COVID-19 Vaccine to Adolescents aged 12 Through 17 Years Download May 6, 2022 StatementCOVID-19 Novavax’ COVID-19 Vaccine Nuvaxovid™ Arrives in Singapore Download May 4, 2022 Statement Novavax Requests Expanded Authorization of Nuvaxovid™ COVID-19 Vaccine to Adolescents Aged 12 through 17 Years in Great Britain* Download May 4, 2022 Novavax to Participate in BofA Securities 2022 Healthcare Conference Download May 2, 2022 Corporate and finance Novavax to Host Conference Call to Discuss First Quarter 2022 Financial Results and Operational Highlights on May 9, 2022 Download Apr 29, 2022 COVID-19 FDA Announces Vaccines and Related Biological Products Advisory Committee Review of Novavax' COVID-19 Vaccine Download Apr 22, 2022 COVID-19 Novavax Announces Initiation of COVID-19 Vaccine Booster Study in Adolescents in Phase 3 PREVENT-19 Trial Download Apr 20, 2022 COVID-19 Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine Download Apr 19, 2022 COVID-19 Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan Download Apr 18, 2022 COVID-19 Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases Download Apr 13, 2022 COVID-19 Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine Download Apr 8, 2022 COVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand Download Mar 31, 2022 Press release Novavax Statement on Arrival of its COVID-19 Vaccine in Canada Download Mar 31, 2022 COVID-19 Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17) Download Mar 25, 2022 COVID-19 Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine Download Mar 22, 2022 COVID-19 Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India Download Mar 10, 2022 Novavax Announces Launch of Global Vaccine Education Programs Download Mar 2, 2022 Novavax to Participate in Cowen's 42nd Annual Health Care Conference Download Feb 28, 2022 Corporate and finance Novavax Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights Download Feb 28, 2022 COVID-19 Novavax Announces Extended Durability of Protection Against Infection and Disease in United Kingdom COVID-19 Vaccine Phase 3 Clinical Trial Download Feb 23, 2022 COVID-19 Novavax Announces Shipments of its COVID-19 Vaccine to European Union Member States Download Feb 21, 2022 Corporate and finance Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights on February 28, 2022 Download Feb 17, 2022 COVID-19 Health Canada Authorizes Novavax COVID-19 Vaccine Download Feb 14, 2022 Press releaseCOVID-19 Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine Download Feb 14, 2022 COVID-19 Novavax Files for Conditional Marketing Authorization of COVID-19 Vaccine in Switzerland Download Feb 11, 2022 Novavax to Participate in Fireside Chat at the 11th Annual SVB Leerink Global Healthcare Conference Download Feb 10, 2022 COVID-19 Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial Download Feb 3, 2022 COVID-19 New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine Download Feb 3, 2022 COVID-19 Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain* Download Jan 31, 2022 COVID-19 Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine Download Jan 28, 2022 COVID-19 Novavax and Israel Announce Advance Purchase Agreement for Supply of COVID-19 Vaccine Download Jan 19, 2022 COVID-19 Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine Download Jan 12, 2022 COVID-19 South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine Download Jan 10, 2022 COVID-19 Novavax and Serum Institute of India File for Emergency Use Authorization of Novavax' COVID-19 Vaccine in South Africa Download Jan 4, 2022 Novavax to Participate in the 40th Annual J.P. Morgan Healthcare Conference Download Dec 31, 2021 COVID-19 Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine Download Dec 28, 2021 COVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India Download Dec 23, 2021 COVID-19 Novavax and SK bioscience Expand Manufacturing Agreement Download Dec 22, 2021 COVID-19 Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies Download Dec 21, 2021 COVID-19 Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study Download Dec 21, 2021 World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine Download Dec 20, 2021 COVID-19 World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine Download Dec 20, 2021 COVID-19 European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine Download Dec 20, 2021 COVID-19 Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine Download Dec 17, 2021 COVID-19 Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine Download Dec 15, 2021 COVID-19 Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine Download Dec 15, 2021 StatementCOVID-19 Novavax Statement on PREVENT-19 Phase 3 Clinical Trial Results Publication in the New England Journal of Medicine Download Dec 13, 2021 COVID-19 Novavax Files for Emergency Use of COVID-19 Vaccine in the United Arab Emirates Download Dec 2, 2021 StatementCOVID-19 Novavax Statement on Omicron Variant Response Download Nov 24, 2021 Corporate and financeCOVID-19 Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore Download Nov 23, 2021 Novavax to Participate in Evercore ISI's 4th Annual HealthCONx Virtual Conference Download Nov 18, 2021 StatementCOVID-19 Novavax Statement on Publication of Positive Results from First Study of Co-administered COVID-19 and Influenza Vaccines Download Nov 17, 2021 COVID-19 Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization Download Nov 17, 2021 Corporate and financeCOVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines Download Nov 15, 2021 Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373 Download Nov 10, 2021 StatementCOVID-19 Novavax Statement on UK and Mexico Phase 3 Clinical Trial Participants Considered Fully Vaccinated in the US Download Nov 4, 2021 Corporate and finance Novavax Reports Third Quarter 2021 Financial Results and Operational Highlights Download Nov 4, 2021 Corporate and financeCOVID-19 Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health Organization Download Nov 3, 2021 COVID-19 Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand Download Nov 1, 2021 COVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia Download Nov 1, 2021 Corporate and financeCOVID-19 Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medicines Agency Download Oct 29, 2021 Corporate and financeCOVID-19 Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia Download Oct 27, 2021 Corporate and financeCOVID-19 Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom Download Oct 20, 2021 StatementCOVID-19 Novavax Reconfirms Confidence in Regulatory Filing Timelines and Manufacturing Quality Download Oct 19, 2021 StatementCOVID-19 Novavax Statement on Initial Com-COV2 Phase 2 Clinical Trial Results Presented at World Vaccine Congress Europe Download Oct 18, 2021 Corporate and finance Novavax to Host Conference Call to Discuss Third Quarter Financial Results and Operational Highlights on November 4, 2021 Download Oct 15, 2021 COVID-19Seasonal influenza Novavax to Participate in World Vaccine Congress Europe Download Oct 11, 2021 StatementCOVID-19 Complete PREVENT-19 Phase 3 Clinical Trial Results Manuscript for COVID-19 Vaccine Posted to medRxiv Download Oct 4, 2021 Corporate and finance Novavax Announces Leadership Appointment and Updates Download Sep 29, 2021 COVID-19 Novavax to Participate in Health Equity and Vaccine Confidence Panel at Maryland Life Sciences Bio Innovation Conference Download Sep 24, 2021 COVID-19 Novavax Hosts HM King Carl XVI Gustaf and HM Queen Silvia of Sweden During Royal Visit to Uppsala County Download Sep 23, 2021 Seasonal influenza Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases Download Sep 23, 2021 COVID-19 Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine Download Sep 23, 2021 Corporate and finance Novavax to Participate in Fireside Chat at the 2021 Cantor Virtual Global Healthcare Conference Download Sep 20, 2021 COVID-19 Novavax to Participate in Fireside Chat at Devex @ UNGA 76 Download Sep 17, 2021 StatementCOVID-19 Novavax Statement on Proof of COVID-19 Vaccine Requirements for PREVENT-19 Clinical Trial Participants in the U.S. Download Sep 16, 2021 COVID-19 Novavax to Participate in University of Oxford Com-COV3 Study Comparing Mixed COVID-19 Vaccine Schedule in Adolescents Download Sep 10, 2021 StatementCOVID-19 Novavax Statement on Takeda Agreement to Provide 150 Million Doses of NVX-CoV2373 to the Government of Japan Download Sep 9, 2021 Corporate and finance Novavax to Participate in Upcoming September Conferences Download Sep 8, 2021 COVID-19 Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza Download Sep 7, 2021 Corporate and finance Novavax to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021 Download Aug 30, 2021 COVID-19 Novavax Statement on CDC Guidance Update for COVID-19 Clinical Trial Participants Download Aug 25, 2021 COVID-19 Novavax to Participate in OCTAVE-DUO Study to Evaluate Third Dose of Vaccine in Participants with Impaired Immune Systems Download Aug 16, 2021 Corporate and finance Novavax Appoints Biopharmaceutical Veterans Jim Kelly as Chief Financial Officer and Nasir Egal, Ph.D., as Senior Vice President of Quality Assurance Download Aug 5, 2021 Novavax Reports Second Quarter 2021 Financial Results and Operational Highlights Download Aug 5, 2021 COVID-19 Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination Download Aug 5, 2021 COVID-19 Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine Download Aug 4, 2021 COVID-19 Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine Download Jul 6, 2021 Corporate and finance Novavax to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights on August 5, 2021 Download Jun 30, 2021 COVID-19 Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine Download Jun 30, 2021 StatementCOVID-19 Novavax Statement on Proof of Vaccination for Phase 3 Clinical Trial Participants: Updated June 30, 2021 Download Jun 22, 2021 StatementCOVID-19 Novavax Statement on Completion of the National Research Council of Canada Biologics Manufacturing Centre Download Jun 17, 2021 Corporate and finance Novavax to Participate in Fireside Chat at SVB Leerink CybeRx Series: Vaccine Forum Download Jun 17, 2021 Corporate and finance Novavax to Participate in National Vaccine Advisory Committee Meeting Download Jun 14, 2021 COVID-19Seasonal influenza Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously Download Jun 14, 2021 COVID-19 Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial Download Jun 11, 2021 COVID-19 Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine Download Show 5102550100 per page«1234»